Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians Journal Article

Local Library Link: Find It @ Loyola

Authors: Tayo, B. O.; Kramer, H; Salako, B. L.; Gottesman, O; McKenzie, C. A.; Ogunniyi, A; Bottinger, E. P.; Cooper, R. S.
Article Title: Genetic variation in APOL1 and MYH9 genes is associated with chronic kidney disease among Nigerians
Abstract: PURPOSE: A region of chromosome 22 which includes APOL1 and MYH9 genes was recently identified as a risk locus for non-diabetic forms of kidney disease, including idiopathic and HIV-associated focal segmental glomerular sclerosis and kidney disease clinically attributed to hypertension among African Americans. The purposes of the current study were, therefore, to examine the frequency of these variants and to determine whether they are associated with chronic kidney disease (CKD) among native Africans. METHODS: To investigate the possible evidence of association between variants in these genes and non-diabetic CKD among West Africans, we performed a case/control analysis in a sample of 166 Nigerians without history of European admixture. Our study included a total of 9 variants on APOL1 (n = 4) and MYH9 (n = 5) genes. RESULTS: We observed significantly strong associations with previously reported APOL1 variants rs73885319 and rs60910145, and their two-allele "G1" haplotype (P 0.005). We did not observe significant evidence of association between non-diabetic CKD and any of the MYH9 variants or haplotypes after accounting for multiple testing in our sample. CONCLUSIONS: In conclusion, APOL1 risk variants are associated with non-diabetic forms of CKD among Nigerians of Yoruba ethnicity. Further information on APOL1/MYH9 variants may lead to screening programs, which could lead to earlier detection and interventions for non-diabetic kidney disease.
Journal Title: International urology and nephrology
Volume: 45
Issue: 2
ISSN: 1573-2584; 0301-1623
Publisher: Unknown  
Journal Place: Netherlands
Date Published: 2013
Start Page: 485
End Page: 494
Language: eng
DOI/URL:

10.1007/s11255-012-0263-4

10.1007/s11255-012-0263-4
Notes: ID: 13173; GR: R01 HL053353/HL/NHLBI NIH HHS/United States; GR: R01 HL053353/HL/NHLBI NIH HHS/United States; JID: 0262521; NIHMS427119; OID: NLM: NIHMS427119; OID: NLM: PMC3599169; 2012/04/08 [received]; 2012/08/07 [accepted]; 2012/09/07 [aheadofprint]; ppublish